Indian CRDMOs form IPSO trade group to boost manufacturing, includes Syngene, Aragen, Piramal & Sai Life Sciences.

Repare Therapeutics cuts 75% of workforce and CMO Maria Koehler departs amid program pause. Multiple companies announce layoffs, funding deals, and trial updates.

FDA ends semaglutide shortage, impacting compounding pharmacies. Hims & Hers plans personalized versions while Olympia ...

Hims & Hers expects revenue from its weight loss business to soar in 2025, even though a recent FDA move could make it ...

Takeda must have liked what it got from the chemoproteomics work out of BridGene Biosciences. The Tokyo-based drugmaker ...

For the fourth year running, Endpoints News will highlight the biotech leaders who are paving the way for the LGBTQ+ ...

Alnylam may be gearing up for its biggest commercial launch yet in its nearly 23-year history, but the company’s top ...

RA Capital leads as most active venture player in private biotech rounds through 2024, with ARCH participating in fewer but ...

Eli Lilly will start selling additional single-dose vials of its weight loss drug Zepbound at a lower price for certain ...

An unusual legal battle over a biotech startup's IPO plans escalated to another level on Valentine's Day, according to two ...

Me CEO Anne Wojcicki and New Mountain Capital propose $2.53/share buyout to take company private, valuing it at $74.7M after ...

Phase 1b US study planned for 2026, as company competes with NS Pharma and Avidity Biosciences in exon 44 space ...